Search
Close this search box.

LifeScale: Innovation in Phenotypic Susceptibility Testing Greater speed and accuracy for your patients, and your lab.​

LifeScale: Innovation in Phenotypic Susceptibility Testing

Greater speed and accuracy for your patients, and your lab.

In a world of rising antimicrobial resistance, Affinity Biosensors is on a mission to provide the fastest diagnostics for your critical-care needs save time, save lives, save costs. 

LifeScale is the only AST using population profiling of individual cell mass, giving the fastest and most accurate AST results available. 

LifeScale is easy on your staff and your budget, and won’t upset your currently optimized workflow. Evaluate LifeScale in your lab today. 

Use LifeScale

When Speed Matters

LifeScale provides rapid results when speed matters most to your patients Gram-negative bacteria in positive blood culture. Its unique population-profiling technology gives results in 4 ½ hours, with the accuracy you demand on the most dangerous resistant strains. LifeScale’s ease-of-use and reliability are proven in the field, with fast sample preparation, and automated inoculation, incubation, read, and report. 

Next-Generation Technology for

Life-Saving Diagnostics

Use LifeScale when speed matters – plate, incubate, measure and report in just 4 ½ hours. 
Superior to growth-based technology, LifeScale’s microfluidic sensor counts and measures the masses of individual organisms. 
Advanced AI analyzes this data to provide the correct MIC in record time. 

LifeScale

Fits in Your Workflow

LifeScale’s benchtop form factor uses the same well-plates and antimicrobials of the most relied-upon ASTs, but provides results in just 4 ½ hours. LifeScale won’t disrupt your lab’s optimized workflowuse it with your rapid blood culture identification system and continue to run most ASTs on your current standard of care.  

LifeScale’s throughput and parallel sample processing will support the demands of most hospitals and keeps impact on your staff to a minimum with easy sample preparation. It’s cost-effective and convenient, with compact consumables that can be stored at room-temperature. 

Headshot of Dr. James Snyder (Ph.D., D(ABMM), F(AAM)), Department of Pathology and Laboratory Medicine University of Louisville Hospital

“Rapid and accurate AST Results are essential in support of antimicrobial stewardship and patient management. The LifeScale rapid AST technology meets these objectives and reduced the duration of empiric therapy. We look forward to implementing it.” 

– Dr. James Snyder (Ph.D., D(ABMM), F(AAM))

Department of Pathology and Laboratory Medicine
University of Louisville Hospital

LifeScale Sees Beyond Growth with

Population Profiling

Our unique mass-sensing technology counts and weighs thousands of individual bacteria, giving a Population Profile of each cultureThis rich data set contains crucial information not available to growth-and metabolism-based ASTs. LifeScale then leverages powerful AI to reliably predict whether a culture will grow, and provide the correct MIC. 

The Fastest and Most Accurate ASTs on the Most Challenging Samples

More and more bacteria are able to outsmart even the most advanced antibiotics. These bacteria hide resistance by delaying their growth, posing a stiff challenge to rapid ASTs reliant on short incubation times. LifeScale’s unique mass-sensing technology and advanced AI has been tested on these samples, outperforming other rapid ASTs and matching or exceeding conventional ASTs that employ long incubation times. 

Latest News &
Announcements

FIRST COAST ID/CM SYMPOSIUM 

February 23-24, 2024 in Jacksonville, FL

SCACM SPRING MEETING 2024

Come see us during the annual SCACM Spring Meeting March 19-22, 2024 in French Lick, IN
at the French Lick Meeting and Event Center

ASM MICROBE 2024

Come see us during the annual ASM Microbe meeting June 13-17, 2024 in Atlanta, GA at
the Georgia World Congress Center

Put LifeScale to the test in your lab, today.

LifeScale’s performance, reliability, and ease of use have been proven in the field. Results at a 600-bed hospital matched the accuracy of a respected standard of care and were available in only 4 ½ hours.